Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2019, Vol. 39 Issue (7): 1-7    DOI: 10.13523/j.cb.20190701
    
Numb Inhibits the Ubiquitination Degradation of p53 by HDM2 in Triple-negative Breast Cancer
Jie XIAN,Xue QIN,You-de CAO()
Teaching and Research Section of Pathology, School of Basic Medical Sciences, Medical University of Chongqing, Chongqing 400016, China
Download: HTML   PDF(941KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Objective : To investigate the decrease of Numb protein expression in triple-negative breast cancer patients and the effect of Numb protein on the p53 protein levels in triple-negative breast cancer and its regulation mechanism, and to further study the correlation between the decrease of Numb protein and the occurrence and development of triple-negative breast cancer, so as to provide a potential new therapeutic target for triple-negative breast cancer without effective treatment.Methods: 40 cases of triple negative breast cancer were taken from Clinical pathology diagnosis centre of Medical University of Chongqing. The expression of Numb protein in triple negative breast cancer patients was detected by immunohistochemistry. MCF-10A cell line and MDA-MB-231 cell line were all ATCC-derived. The mRNA and protein levels of Numb, HDM2 and p53 were compared by qPCR and Western blot. Numb was re-expressed in MDA-MB-231 cells by plasmid transfection. The expression of Numb, HDM2 and p53 was verified by qPCR and Western blot.Results: After transfection with NUMB-EGFP, the mRNA and protein levels of Numb in MDA-MB-231 cells were significantly increased, HDM2 did not change evidently, and p53 did not change significantly at the mRNA levels, but increased remarkably at the protein levels. The increased of Numb protein in NUMB-EGFP-transfected cells can regulate the p53 levels at post-transcriptional level, resulting in a significant increase of p53 protein levels.Conclusion: The expression of Numb protein in triple-negative breast cancer patients decreased by 55%, and Numb protein can regulate the level of p53 protein in triple-negative breast cancer cell line MDA-MB-231. The level of Numb protein is positively correlated with the level of p53 protein.



Key wordsTriple-negative breast cancer      Numb protein      HDM2 protein      p53 protein     
Received: 16 January 2019      Published: 05 August 2019
ZTFLH:  Q819  
Corresponding Authors: You-de CAO     E-mail: 420306100@qq.com
Cite this article:

Jie XIAN,Xue QIN,You-de CAO. Numb Inhibits the Ubiquitination Degradation of p53 by HDM2 in Triple-negative Breast Cancer. China Biotechnology, 2019, 39(7): 1-7.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20190701     OR     https://manu60.magtech.com.cn/biotech/Y2019/V39/I7/1

Gene Forward primer(5'to3') Reverse primer( 5'to3')
Numb GGACACAGGTGAAAGGTTGAGC AGTGGCTGTTGTGACACGGAAT
HDM2 CTACAGGGACGCCATCGAATC TGAAGTGCATTTCCAATAGTCAGC
TP53 TGCGTGTTTGTGCCTGTCCT AGTGCTCGCTTAGTGCTCCCT
GAPDH CTTTGGTATCGTGGAAGGACTC GTAGAGGCAGGGATGATGTTCT
Table1 The sequence of Primers for PCR(pig)
Fig.1 Numb expression in normal breast tissue and triple-negative breast cancers (a) The expression of Numb in normal mammary tissue detected by immunohistochemistry (b) Examples of a retained (score 2,<10% positive tumor cells), b reduced (score 1, 10%-50% positive tumor cells) and c deficient (score 0, >50% positive tumor cells), expression of Numb (c) In the triple negative breast cancer group, 22 cases (55% ) had decreased Numb expression and 18 cases (45%) had retained Numb expression
临床特征 三阴乳腺癌病例数
(n=40)
Numb表达正常n=18
(45%)
Numb表达降低n=22
(55%)
P value
年龄
≤ 50
>50

23
17

10
8

13
9
>0.05

肿瘤大小
≤ 2cm
>2cm

18
22

8
10

10
12
>0.05

淋巴结转移情况
Positive(n>0)
Negative(n=0)

15
25

7
11

8
14
>0.05

Ki67
≤14%
>14%

5 (12.5%)
35 (87.5%)

5(27.8%)
13 (72.2%)

0 (0%)
22(100%)
<0.05

Table 2 Associations between Numb expression and patient and tumor characteristics
Fig.2 The expression of Numb, HDM2 and p53 in MCF-10A and MDA-MB-231 cell lines (a) Quantitative RT-PCR detection of Numb, HDM2 and p53 levels in MDA-MB-231 and MCF-10A (b)The protein expression of Numb,HDM2 and p53 in different cell fractions of MDA-MB-231 and MCF-10A was determined by Western blot (c) Quantitative analysis of Numb, HDM2 and p53 expression in MDA-MB-231 and MCF-10A ( Mean ± SD, n = 3, ** P< 0.01)
Fig.3 Numb, HDM2 and p53 levels in the NUMB-EGFP-transfected MDA-MB-231 cells (a) Quantitative RT-PCR detection of Numb, HDM2 and p53 levels in NUMB-EGFP-transfected MDA-MB-231 cells (b) The protein expression of Numb, HDM2 and p53 in NUMB-EGFP-transfected MDA-MB-231 cells was determined by Western blot (c) Quantitative analysis of Numb, HDM2 and p53 proteins in NUMB-EGFP-transfected cells (Mean±SD, n=3, ** P<0.01, vs blank group or EGFP group)
[1]   Pece S, Serresi M, Santolini E , et al. Loss of negative regulation by Numb over notch is relevant to human breast carcinogenesis. J Cell Biol, 2004,167(2):215-221.
doi: 10.1083/jcb.200406140
[2]   Di Marcotullio L, Ferretti E, Greco A , et al. Numb is a suppressor of hedgehog signallingand targets gli1 for itch-dependent ubiquitination. Nature , 2006,8(12):1415-1423.
[3]   Cahilly-Snyder L, Yang-Feng T, Francke U , et al. Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Somat Cell Mol Genet, 1987,13(3):235-244.
doi: 10.1007/BF01535205
[4]   Vousden K H, Prives C . P53 and prognosis:new insights and further complexity. Cell, 2005,120(1):7-10.
[5]   Momand J, Wu H H, Dasgupta G , et al. MDM2-master regulator of the p53 tumor suppressor protein. Gene, 2000,242(1/2):15-29.
doi: 10.1016/S0378-1119(99)00487-4
[6]   Hutterer A, Knoblich J A . Numb and a-adaptin regulate sanpodo endocytosis to specify cell fate in drosophilaexternal sensoryorgans. EMBO Rep, 2005,6(9):836-842.
doi: 10.1038/sj.embor.7400500
[7]   Foulkes W D, Smith I E, Reis-Filho J S , et al. Triple-negative breast cancer. N Engl J Med, 2010,363(20):1938-1948.
doi: 10.1056/NEJMra1001389
[8]   Pece S, Confalonieri S, Di Fiore P P , et al. NUMB-ing down cancer by more than just a NOTCH. Biochim Biophys Acta, 2011,1815(1):26-43.
[9]   Shen Q, Zhong W, Jan Y , et al. Asymmetric numb distribution is critical for asymmetric cell division of mouse cerebral cortical stem cells and neuroblasts. Development , 2002,129(20):4843-4853.
[10]   Colaluca I N, Tosoni D, Nuciforo P , et al. NUMB controls p53 tumour suppressor activity. Nature, 2008,451(7174):76-81.
[11]   Zhang Y, Li F Y, Song Y L , et al. Numb and Numbl act to determine mammary myoepithelial cell fate,maintain epithelial identity,and support lactogenesis. FASEB, 2016,30(10):3474-3488.
doi: 10.1096/fj.201600387R
[12]   Rhyu M S, Jan L Y, Jan Y N . Asymmetric distribution of numb protein during division of the sensory organ precursor cell confers distinct fates to daughter cells. Cell, 1994,76(3):477-491.
doi: 10.1016/0092-8674(94)90112-0
[13]   Juven-Gershon T, Shifman O, Unger T , et al. The mdm2 oncoprotein interacts with the cell fate regulator Numb. Mol Cell Biol, 1998,18(7):3974-3982.
doi: 10.1128/MCB.18.7.3974
[14]   Berdnik D, Török T, Gonzalez-Gaitan M , et al. The endocytic proteina-adaptin is required for numb-mediated asymmetric cell division in drosophila. Dev Cell , 2002,3(2):221-231.
doi: 10.1016/S1534-5807(02)00215-0
[15]   Vassilev L T, Vu B T, Graves B , et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science, 2004,303(5659):844-848.
doi: 10.1126/science.1092472
[16]   Tosoni1 D, Pambianco1 S, Ekalle Soppo B , et al. Re-clinical validation of a selective anti-cancer stem cell therapy for Numb-deficient human breast cancer. EMBO Mol Med, 2017,7(5):656-671.
[17]   Ray-Coquard I, Blay J Y, Italiano A , et al. Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study. Lancet Oncol , 2012,13(11):1133-1140.
doi: 10.1016/S1470-2045(12)70474-6
[18]   Pece S, Confalonieri S, R Romano P , et al. NUMB-ing downcancer by more than just a NOTCH. Biochim Biophys Acta, 2011,1815(1):26-43.
[19]   Enari M, Ohmori K, Kitabayashi I , et al. Requirement of clathrin heavy chain for p53-mediated transcription. Genes Dev, 2006,20(9):1087-1099.
doi: 10.1101/gad.1381906
[20]   Cayouette M, Raff M , et al. Asymmetric segregation of Numb: a mechanism for neural specification from Drosophila to mammals. Nature Neurosci, 2002,5(12):1265-1269.
[1] . [J]. China Biotechnology, 2021, 41(12): 1-3.
[2] WU Han-rong,WANG Ying,HUANG Ying-ming,LI Dong-xue,LI Zhi-fei,FANG Zi-han,FAN Lin. Promote the Innovation and Transformation of Biotechnology by Base Platform[J]. China Biotechnology, 2021, 41(12): 141-147.
[3] YIN Ze-chao,WANG Xiao-fang,LONG Yan,DONG Zhen-ying,WAN Xiang-yuan. Advances on Genetic Research and Mechanism Analysis on Maize Resistance to Ear Rot[J]. China Biotechnology, 2021, 41(12): 103-115.
[4] LENG Yan,SUN Kang-tai,LIU Qian-qian,PU A-qing,LI Xiang,WAN Xiang-yuan,WEI Xun. Trends of Global Gene-edited Crops Supervision[J]. China Biotechnology, 2021, 41(12): 24-29.
[5] HE Wei,ZHU Lei,LIU Xin-ze,AN Xue-li,WAN Xiang-yuan. Research Progress on Maize Genetic Transformation and Commercial Development of Transgenic Maize[J]. China Biotechnology, 2021, 41(12): 13-23.
[6] YANG Meng-bing,JIANG Yi-lin,ZHU Lei,AN Xue-li,WAN Xiang-yuan. CRISPR/Cas Plant Genome Editing Systems and Their Applications in Maize[J]. China Biotechnology, 2021, 41(12): 4-12.
[7] YIN Fang-bing,WANG Cheng,LONG Yan,DONG Zhen-ying,WAN Xiang-yuan. Progress on Dissecting Genetic Architecture and Formation Mechanism of Maize Ear Traits[J]. China Biotechnology, 2021, 41(12): 30-46.
[8] QIN Wen-xuan,LIU Xin,LONG Yan,DONG Zhen-ying,WAN Xiang-yuan. Progress on Genetic Analysis and Molecular Dissection on Maize Leaf Angle Traits[J]. China Biotechnology, 2021, 41(12): 74-87.
[9] WANG Rui-pu,DONG Zhen-ying,GAO Yue-xin,LONG Yan,WAN Xiang-yuan. Research Progress on Genetic Structure and Regulation Mechanism on Starch Content in Maize Kernel[J]. China Biotechnology, 2021, 41(12): 47-60.
[10] MA Ya-jie,GAO Yue-xin,LI Yi-ping,LONG Yan,DONG Zhen-ying,WAN Xiang-yuan. Progress on Genetic Analysis and Molecular Dissection on Maize Plant Height and Ear Height[J]. China Biotechnology, 2021, 41(12): 61-73.
[11] WANG Yan-bo,WEI Jia,LONG Yan,DONG Zhen-ying,WAN Xiang-yuan. Research Advances on Genetic Structure and Molecular Mechanism Underlying the Formation of Tassel Traits in Maize[J]. China Biotechnology, 2021, 41(12): 88-102.
[12] MAO Kai-yun,LI Rong,LI Dan-dan,ZHAO Ruo-chun,FAN Yue-lei,JIANG Hong-bo. Analysis of the Current Status of Global Bispecific Antibody Development[J]. China Biotechnology, 2021, 41(11): 110-118.
[13] WU Han-rong,WANG Ying,YANG Li,GE Yao,FAN Ling. Current Situation and Development Suggestions of China’s Biotechnology Base Platform[J]. China Biotechnology, 2021, 41(11): 119-123.
[14] LIU Tian-yi,FENG Hui,SALSABEEL Yousuf,XIE Ling-li,MIAO Xiang-yang. Research Progress of lncRNA in Animal Fat Deposition[J]. China Biotechnology, 2021, 41(11): 82-88.
[15] XUE Zhi-yong,DAI Hong-sheng,ZHANG Xian-yuan,SUN Yan-ying,HUANG Zhi-wei. Effects of Vitreoscilla Hemoglobin Gene on Growth and Intracellular Oxidation State of Saccharomyces cerevisiae[J]. China Biotechnology, 2021, 41(11): 32-39.